These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1268 related items for PubMed ID: 12826021

  • 1. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C, Alegre J, Monasterio J, Segura RM, Armadans L, Anglés A, Varela E, Ruiz E, Fernández de Sevilla T.
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [Abstract] [Full Text] [Related]

  • 2. Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions.
    Lin FC, Chen YC, Chen FJ, Chang SC.
    Clin Immunol; 2005 Aug; 116(2):166-73. PubMed ID: 15897010
    [Abstract] [Full Text] [Related]

  • 3. Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions.
    Iglesias D, Alegre J, Alemán C, Ruíz E, Soriano T, Armadans LI, Segura RM, Anglés A, Monasterio J, de Sevilla TF.
    Eur Respir J; 2005 Jan; 25(1):104-9. PubMed ID: 15640330
    [Abstract] [Full Text] [Related]

  • 4. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates.
    Chung CL, Chen CH, Sheu JR, Chen YC, Chang SC.
    Chest; 2005 Aug; 128(2):690-7. PubMed ID: 16100155
    [Abstract] [Full Text] [Related]

  • 5. Fibrinolytic and inflammatory processes in pleural effusions.
    Philip-Joët F, Alessi MC, Philip-Joët C, Aillaud M, Barriere JR, Arnaud A, Juhan-Vague I.
    Eur Respir J; 1995 Aug; 8(8):1352-6. PubMed ID: 7489803
    [Abstract] [Full Text] [Related]

  • 6. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS, Kostikas K, Oikonomidi S, Tsilioni I, Nikoulis D, Germenis A, Gourgoulianis KI.
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of ferritin, interleukin-6, interleukin-8 and tumor necrosis factor alpha in the differentiation of exudates and transudates in pleural effusions.
    Alexandrakis MG, Coulocheri SA, Bouros D, Eliopoulos GD.
    Anticancer Res; 1999 May; 19(4C):3607-12. PubMed ID: 10629659
    [Abstract] [Full Text] [Related]

  • 8. Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions.
    Hua CC, Chang LC, Chen YC, Chang SC.
    Chest; 1999 Nov; 116(5):1292-6. PubMed ID: 10559090
    [Abstract] [Full Text] [Related]

  • 9. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
    Hamed EA, El-Noweihi AM, Mohamed AZ, Mahmoud A.
    Respirology; 2004 Mar; 9(1):81-6. PubMed ID: 14982607
    [Abstract] [Full Text] [Related]

  • 10. Analysis of Cytokine Levers in Pleural Effusions of Tuberculous Pleurisy and Tuberculous Empyema.
    Yang L, Hu YJ, Li FG, Chang XJ, Zhang TH, Wang ZT.
    Mediators Inflamm; 2016 Mar; 2016():3068103. PubMed ID: 27034588
    [Abstract] [Full Text] [Related]

  • 11. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
    Altmann ES, Crossingham I, Wilson S, Davies HR.
    Cochrane Database Syst Rev; 2019 Oct 30; 2019(10):. PubMed ID: 31684683
    [Abstract] [Full Text] [Related]

  • 12. IL-8 in pleural effusion.
    Ceyhan BB, Ozgün S, Celikel T, Yalçin M, Koç M.
    Respir Med; 1996 Apr 30; 90(4):215-21. PubMed ID: 8736655
    [Abstract] [Full Text] [Related]

  • 13. Thrombin-antithrombin III complex, proinflammatory cytokines, and fibrinolytic indices for assessing the severity of inflammation in pleural effusions.
    Lee MH, Nahm CH, Choi JW.
    Ann Clin Lab Sci; 2010 Apr 30; 40(4):342-7. PubMed ID: 20947808
    [Abstract] [Full Text] [Related]

  • 14. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease.
    Robinson SD, Dawson P, Ludlam CA, Boon NA, Newby DE.
    Clin Sci (Lond); 2006 Mar 30; 110(3):353-60. PubMed ID: 16309383
    [Abstract] [Full Text] [Related]

  • 15. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
    Brommer EJ, Dooijewaard G, Dijkmans BA, Breedveld FC.
    Thromb Haemost; 1992 Aug 03; 68(2):180-4. PubMed ID: 1412164
    [Abstract] [Full Text] [Related]

  • 16. Repeated thoracenteses affect proinflammatory cytokines, vascular endothelial growth factor, and fibrinolytic activity in pleural transudates.
    Chung CL, Yeh CY, Sheu JR, Chen YC, Chang SC.
    Am J Med Sci; 2007 Dec 03; 334(6):452-7. PubMed ID: 18091367
    [Abstract] [Full Text] [Related]

  • 17. Pathways of fibrin turnover of human pleural mesothelial cells in vitro.
    Idell S, Zwieb C, Kumar A, Koenig KB, Johnson AR.
    Am J Respir Cell Mol Biol; 1992 Oct 03; 7(4):414-26. PubMed ID: 1389210
    [Abstract] [Full Text] [Related]

  • 18. Hyaluronic acid levels are increased in complicated parapneumonic pleural effusions.
    Zaga T, Makris D, Tsilioni I, Kiropoulos T, Oikonomidi S, Damianos A, Gourgoulianis KI.
    Monaldi Arch Chest Dis; 2011 Sep 03; 75(3):167-71. PubMed ID: 22428219
    [Abstract] [Full Text] [Related]

  • 19. Abnormalities of pathways of fibrin turnover in the human pleural space.
    Idell S, Girard W, Koenig KB, McLarty J, Fair DS.
    Am Rev Respir Dis; 1991 Jul 03; 144(1):187-94. PubMed ID: 2064128
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema.
    Broaddus VC, Hébert CA, Vitangcol RV, Hoeffel JM, Bernstein MS, Boylan AM.
    Am Rev Respir Dis; 1992 Oct 03; 146(4):825-30. PubMed ID: 1416405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.